AKOYA BIOSCIENCES INC (AKYA)
US00974H1041 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 83.13M | 74.20M | 113.10M | 17.00M | 11.60M | |||
| Marketable Securities | N/A | 7.00M | N/A | 0.00 | 10.00M | |||
| Receivables | 16.99M | 9.70M | 9.40M | 6.50M | 13.20M | |||
| Inventories | 17.88M | 14.50M | 9.00M | 4.30M | 4.10M | |||
| Other Current Assets | 3.79M | 6.80M | 9.30M | 1.00M | 2.00M | |||
| Total Current Assets | 121.79M | 112.20M | 140.80M | 28.70M | 40.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 21.55M | 24.50M | 10.00M | 7.00M | 5.50M | |||
| Goodwill | 18.26M | 18.30M | 18.30M | 18.30M | 18.30M | |||
| Intangibles | 17.41M | 20.00M | 21.20M | 22.70M | 24.10M | |||
| Other Non-Current Assets | 1.36M | 1.00M | 600.00K | 1.00M | 700.00K | |||
| Total Non-Current Assets | 58.58M | 63.80M | 50.10M | 49.00M | 48.50M | |||
| TOTAL ASSETS | 180.37M | 176.00M | 190.90M | 77.70M | 89.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 767.00K | 600.00K | 300.00K | 1.20M | 100.00K | |||
| Accrued Expenses | 13.11M | 17.80M | 12.30M | 5.40M | 6.00M | |||
| Accounts Payable | 11.78M | 10.60M | 9.40M | 5.10M | 8.10M | |||
| Other Current Liabilities | 9.70M | 8.00M | 5.70M | 5.40M | 6.90M | |||
| Total Current Liabilities | 35.34M | 37.10M | 27.70M | 17.20M | 21.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 76.02M | 64.00M | 32.70M | 33.80M | 24.70M | |||
| Deferred Taxes/Income | 38.00K | 100.00K | 0.00 | 200.00K | 200.00K | |||
| Other Non-Current Liabilities | 15.20M | 16.40M | 9.20M | 8.50M | 9.20M | |||
| Total Non-Current Liabilities | 91.25M | 80.40M | 41.90M | 42.40M | 34.00M | |||
| TOTAL LIABILITIES | 126.60M | 117.50M | 69.60M | 59.60M | 55.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -230.07M | -166.70M | -96.10M | -52.30M | -31.40M | |||
| Additional Paid In Capital | 283.84M | 225.30M | 217.50M | 0.00 | 0.00 | |||
| Common Shares | 2.00K | 0.00 | 0.00 | 70.40M | 65.60M | |||
| Other Shareholders' Equity | 0.00 | 0.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 49.12M | 38.30M | 37.40M | 35.70M | 35.70M | |||
| Tangible Book Value per Share | 0.37 | 0.53 | 2.19 | -2.61 | -2.07 | |||
| Total Shareholders' Equity | 53.77M | 58.60M | 121.40M | 18.10M | 34.20M | |||
| TOTAL LIABILITIES AND EQUITY | 180.37M | 176.00M | 190.90M | 77.70M | 89.40M | |||
| Statistics | ||||||||
| Debt/Equity | 1.41 | 1.09 | 0.27 | 1.87 | 0.72 | |||
| Current Ratio | 3.45 | 3.02 | 5.08 | 1.67 | 1.93 | |||
| Return On Assets (ROA) | -35.11% | -40.14% | -23.24% | -28.01% | -20.48% | |||
| Return On Equity (ROE) | -117.77% | -120.55% | -36.55% | -120.22% | -53.54% | |||
All data in USD